Journal issue overview 6/2007 Internal Medicine

632

Clinical experience in treatment with the long-term insulin analogue glargin in a diabetes centre

I. Haladová, S. Lacigová, Z. Jankovec, D. Čechurová, M. Žourek, M. Krčma, Z. Rušavý

637

The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI)

J. Olšovský, M. Beránek

646

The subpopulation of CD34⁺ cells and their importance in the healing of grafts in family-related allogenic transplants of peripheral stem cells.

M. Klabusay, V. Suková, Z. Kořístek, J. Mayer, J. Vorlíček

653

Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin^® till the end of 2006

M. Penka, J. Schwarz, T. Pavlík, R. Pytlík, M. Doubek, P. Ďulíček, J. Kissová, A. Hluší, M. Schutzova, O. Černá, Y. Brychtová, T. Szotkowski, Z. Volková, J. Seghetová, V. Vozobulová, I. Hadačová, I. Hochová, J. Voglová, T. Lhoťanová, B. Bubeník, M. Vránová, M. Mičaníková, L. Dušek

662

The optimum length of anticoagulation therapy after venous thromboembolism - universal or individualised approach?

J. Hirmerová

669

Cardiotoxicity of antracycline treatment in the light of new biochemical diagnostic options

D. Urbanová, B. Mladosievičová

678

Genetic factors and the risk of cardiovascular diseases

A. Teren, P. Gavornik

694

New knowledge in the heredity of autoimmune diabetes.
1st part – Monogenetically determined types of autoimmune diabetes

J. Vavřinec, J. Vosáhlo